|
Volumn 93, Issue 13, 2001, Pages 963-965
|
Tamoxifen and contralateral breast cancer: The other side
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIESTROGEN;
ESTROGEN RECEPTOR;
PLACEBO;
RALOXIFENE;
TAMOXIFEN;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER REGISTRY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG MECHANISM;
EDITORIAL;
FEMALE;
HORMONE SENSITIVITY;
HUMAN;
METASTASIS;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
|
EID: 0035806487
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/93.13.963 Document Type: Editorial |
Times cited : (13)
|
References (15)
|